Home
About
Overview
Sharing Data
ORCID
Help
History (23)
Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia.
Assessment of variables associated with smoking cessation in Crohn's disease.
Linking Inflammation, Cardiorespiratory Variability, and Neural Control in Acute Inflammation via Computational Modeling.
Shi, Lewis
Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease.
Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease. Drugs. 2004; 64(16):1767-77.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Autoantibodies
Clinical Protocols
Clinical Trials as Topic
Crohn Disease
Hemodynamics
Humans
Immunosuppressive Agents
Infliximab
Infusions, Intravenous
Lupus Erythematosus, Systemic
Neoplasms
Nervous System Diseases
Tumor Necrosis Factor-alpha
authors with profiles
Russell D. Cohen